1. Home
  2. APRE vs AREB Comparison

APRE vs AREB Comparison

Compare APRE & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • AREB
  • Stock Information
  • Founded
  • APRE 2006
  • AREB 2014
  • Country
  • APRE United States
  • AREB United States
  • Employees
  • APRE N/A
  • AREB N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • AREB Plastic Products
  • Sector
  • APRE Health Care
  • AREB Industrials
  • Exchange
  • APRE Nasdaq
  • AREB Nasdaq
  • Market Cap
  • APRE 9.4M
  • AREB 8.4M
  • IPO Year
  • APRE 2019
  • AREB N/A
  • Fundamental
  • Price
  • APRE $1.54
  • AREB $0.76
  • Analyst Decision
  • APRE Strong Buy
  • AREB
  • Analyst Count
  • APRE 1
  • AREB 0
  • Target Price
  • APRE $20.00
  • AREB N/A
  • AVG Volume (30 Days)
  • APRE 34.4K
  • AREB 1.4M
  • Earning Date
  • APRE 11-06-2025
  • AREB 11-11-2025
  • Dividend Yield
  • APRE N/A
  • AREB N/A
  • EPS Growth
  • APRE N/A
  • AREB N/A
  • EPS
  • APRE N/A
  • AREB N/A
  • Revenue
  • APRE $841,012.00
  • AREB $9,474,958.00
  • Revenue This Year
  • APRE N/A
  • AREB N/A
  • Revenue Next Year
  • APRE N/A
  • AREB N/A
  • P/E Ratio
  • APRE N/A
  • AREB N/A
  • Revenue Growth
  • APRE N/A
  • AREB N/A
  • 52 Week Low
  • APRE $1.41
  • AREB $0.52
  • 52 Week High
  • APRE $5.01
  • AREB $193.48
  • Technical
  • Relative Strength Index (RSI)
  • APRE 43.27
  • AREB 36.72
  • Support Level
  • APRE $1.49
  • AREB $0.52
  • Resistance Level
  • APRE $1.66
  • AREB $0.89
  • Average True Range (ATR)
  • APRE 0.08
  • AREB 0.10
  • MACD
  • APRE 0.00
  • AREB -0.01
  • Stochastic Oscillator
  • APRE 27.00
  • AREB 36.01

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: